News

The interim analysis from the trial was presented during the thirteenth European Cancer Conference in Paris. More than 900 patients with advanced kidney cancer participated in the international

Tarceva is the first drug in a phase III trial to have shown a significant improvement in overall survival when added to gemcitabine chemotherapy as initial treatment for

According to the company, the project is on track to be the largest drug donation program in global pharmaceutical industry history. The project has the aim of eradicating

J&J claims that the recent recalls have had a material adverse effect on Guidant, and, as a result, that it is not required under the terms of the

The study showed that, after a year, one patient out of every four was still alive when treated with Xeloda plus standard chemotherapy, compared to one in five

The collaboration is focused on identifying genetic profiles that correlate with drug response to more effectively guide the clinical and market development of Merck’s cancer compounds. Under the

The trial enrolled 160 patients with the disorder in 11 centers across the US. Patients in the AT-001 arm of the trial received 25mg of AT-001 daily for

While the research, initiated in August 2003, was initially focused on one class of compounds, the two companies have agreed to broaden the field of investigation based on

The phase II study in metastatic breast cancer is an open label, multicenter study being managed by US Oncology, a healthcare services network focused on cancer treatment and